Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems

Schizophrenia Bulletin

Volumn 39, Issue 2, 2013, Pages 366-377

  Dawson, Neil ^a,b   Morris, Brian J ^a,c   Pratt, Judith A ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

2 deoxyglucose autoradiographic imaging; NMDA receptor; partial least squares regression

Indexed keywords

DEOXYGLUCOSE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN METABOLISM; CONNECTOME; CONTROLLED STUDY; DENTATE GYRUS; DIAGONAL BAND OF BROCA; DORSAL RAPHE NUCLEUS; ELECTROENCEPHALOGRAM; ENTORHINAL CORTEX; HYPERMETABOLISM; INFERIOR COLLICULUS; INTERPEDUNCULAR NUCLEUS; LOCUS CERULEUS; MALE; MAMMILLARY BODY; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PONTINE NUCLEUS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RETROSPLENIAL CORTEX; SUBICULUM; SUBSTANTIA NIGRA PARS COMPACTA; SUBSTANTIA NIGRA PARS RETICULATA; THALAMUS NUCLEUS; THALAMUS RETICULAR NUCLEUS; VENTRAL TEGMENTUM;

ANESTHETICS, DISSOCIATIVE; ANIMALS; CARBON RADIOISOTOPES; DEOXYGLUCOSE; DISEASE MODELS, ANIMAL; KETAMINE; MALE; MICE; MICE, INBRED C57BL; NEURAL PATHWAYS; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; RADIOPHARMACEUTICALS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; THALAMIC NUCLEI;

EID: 84874535181     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbr144     Document Type: Article

References (40)

1. Lynall ME, Bassett DS, Kerwin R, et al. Functional connectivity and brain networks in schizophrenia. J Neurosci. 2010;30:9477-9487.
2. Hill K, Mann L, Laws KR, Stephenson CM, Nimmo-Smith I, McKenna PJ. Hypofrontality in schizophrenia: a metaanalysis of functional imaging studies. Acta Psychiatr Scand. 2004;110:243-256. (Pubitemid 39278982)
3. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurones in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 1991;48:996-1001.
4. Joyce E, Hutton S, Mutsatsa S, Gibbins H, Webb E, Paul S. Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry. 2002;181:s38-s44. (Pubitemid 34983511)
5. Krystal JH, Karper LP, Seibyl JP, et al. Subanaesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch Gen Psychiatry. 1994;51: 199-214. (Pubitemid 24081509)
6. Lahti AC, Weiler MA, Michaelidis T, Parwani A, Tamminga CA. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology. 2001;25:455-467. (Pubitemid 32830950)
7. Egerton A, Reid L, McGregor S, Cochran SM, Morris BJ, Pratt JA. Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. Psychopharmacology. 2008;198: 37-49.
8. Pitsikas N, Boultadakis A, Sakellaridis N. Effects of sub-anaesthetic doses of ketamine on rats' spatial and non-spatial recognition memory. Neuroscience. 2008;154:454-460.
9. Sams-Dodd F. Phencyclidine in the social interaction test: an animal models of schizophrenia with face and predictive validity. Rev Neurosci. 1999;10:59-90. (Pubitemid 29396547)
10. Dawson N, Thompson RJ, McVie A, Thomson DM, Morris BJ, Pratt JA. Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism and functional brain connectivity [published online ahead of print September 1, 2011]. Schizophr Bull. doi:10.1093/schbull/sbq090.
11. Cochran SM,KennedyM,McKercharCE, StewardLJ, Pratt JA, Morris BJ. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology. 2003;28:265-275.
12. Morris BJ, Cochran SM, Pratt JA. PCP: from pharmacology to modelling schizophrenia. Curr Opin Pharmacol. 2005;5:101-106. (Pubitemid 40124542)
13. Langsjo JW, Salmi E, Kaisti KK, et al. Effects of subanaesthetic Ketamine on regional cerebral glucose metabolism in humans. Anesthesiology. 2004;100:1065-1071. (Pubitemid 38541959)
14. Homayoun H, Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci. 2007;27:11496-11500. (Pubitemid 350006886)
15. Lopez-Gil X, Babot Z, Amargos-Bosch M, Sunol C, Artigas F, Adell F. Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat. Neuropsychopharmacology. 2007;32:2087-2097. (Pubitemid 47417703)
16. McIntosh AR, Bookstein FL, Haxby JV, Grady CL. Spatial pattern analysis of functional brain images using partial least squares. Neuroimage. 1996;3:143-157. (Pubitemid 26199050)
17. Krause M, Hoffman WE, Hajos M. Auditory sensory gating in hippocampus and reticular thalamic neurones in anaesthetized rats. Biol Psychiatry. 2003;53:244-253. (Pubitemid 36135936)
18. McCormick DA, Bal T. Sleep and arousal: thalamocortical mechanisms. Annu Rev Neurosci. 1997;20:185-212.
19. Jacobsen RB, Ulrich D, Hugenard JR. GABAB and NMDA receptors contribute to spindle-like oscillations in rat thalamus in vitro. J Neurophysiol. 2001;86:1365-1375. (Pubitemid 32847781)
20. Ferrarelli F, Huber R, Peterson MJ, et al. Reduced sleep spindle activity in schizophrenic patients. Am J Psychiatry. 2007;164:483-492. (Pubitemid 46513163)
21. Zikopoulos B, Barbas H. Prefrontal projections to the thalamic reticular nucleus form a unique circuit for attentional mechanisms. J Neurosci. 2006;26:7348-7361. (Pubitemid 44315202)
22. Zhang Y, Llinas RR, Lisman JE. Inhibition of NMDARs in the nucleus reticularis of the thalamus produces delta frequency bursting. Front Neural Circuits. 2009;3:1-9.
23. Rotaru DC, Yoshino H, Lewis DA, Ermentrout GB, Gonzalez-Burgos G. Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia. J Neurosci. 2011;31:142-156.
24. Cochran SM, Fujimara M, Morris BJ, Pratt JA. Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain. Synapse. 2002;46:206-214. (Pubitemid 35155173)
25. Ferrarelli F, Tononi G. The thalamic reticular nucleus and schizophrenia. Schizophr Bull. 2011;37:306-315.
26. Yan QS, Reith MEA, Jobe P, Dailey JW. Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res. 1997;765:149-158. (Pubitemid 27374926)
27. Aghajanian GK, Marek GJ. Serotonin model of schizophrenia: emerging role of glutatmate mechanisms. Brain Res Rev. 2000;31:302-312. (Pubitemid 30136185)
28. Feng J, Cai X, Zhao JH, Yan Z. Serotonin receptors modulate GABAA receptor channels through the activation of anchored protein kinase C in prefrontal cortical neurones. J Neurosci. 2001;21:6502-6511. (Pubitemid 32781094)
29. Aghajanian GK, Marek GJ. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of the prefrontal cortex by an asynchronous mode of glutamate release. Brain Res. 1999;825:161-171. (Pubitemid 29222872)
30. Mantz J, Godbout R, Tassin JP, Glowinski J, Thierry AM. Inhibition of spontaneous and evoked unit activity in the rat medial prefrontal cortex by mesencephalic raphé nuclei. Brain Res. 1990;524:22-30. (Pubitemid 20254691)
31. Clarke HF, Walker SC, Crofts HS, Dalley JW, Robbins TW, Roberts AC. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci. 2005;25:532-538. (Pubitemid 40105626)
32. Winstanley CA, Theobald DEH, Dalley JW, Cardinal RN, Robbins TW. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex. 2006;16:106-114. (Pubitemid 41746734)
33. Williams GV, Rao SG, Goldman-Rakic PS. The physiological role of 5-HT2A receptors in working memory. J Neurosci. 2002;22:2843-2854. (Pubitemid 37465833)
34. VartyGB, Bakshi VP,Geyer MA.M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology. 1999;20:311-321.
35. Lapiz MDS, Morilak DA. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience. 2006;137:1039-1049. (Pubitemid 43053965)
36. Ramos BP, Arnsten AFT. Adrenergic pharmacology and cognition: focus on prefrontal cortex. Pharmacol Ther. 2007; 113:523-536. (Pubitemid 46365960)
37. Gaykema RPA, Luiten PGM, Nyakas C, Traber J. Cortical projection patterns of the medial septum-diagonal band complex. J Comp Neurol. 1990;293:103-124. (Pubitemid 20092475)
38. Nelson CL, Burk JA, Bruno JP, Sarter M. Effects of acute and systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Psychopharmacology. 2002;161:168-179. (Pubitemid 34492662)
39. Broersen LM, Heisbroek RPW, de Bruin JPC, Uylings HDB, Olivier B. The role of the medial prefrontal cortex in shortterm memory functioning: further support for the involvement of cholinergic, rather than dopaminergic mechansism. Brain Res. 1995;674:221-229.
40. Sato K, Wu J, Kikuchi T, Wang Y, Watanabe I, Okumaura F. Differential effects of ketamine and pentobarbitone on acetylcholine release from the rat hippocampus and striatum. Br J Anaesth. 1996;77:381-384. (Pubitemid 26300867)